用于SARS-CoV-2进入受体ACE2的PET显像的放射性氟化MLN-4760衍生物的研制
本研究合成并评估了ACE2抑制剂MLN-4760的两种放射性氟化衍生物[18F]F-MLN-4760和[18F]F-Aza-MLN-4760,用于ACE2的PET显像。计算机建模和共结晶证实F-MLN-4760与hACE2结合模式与MLN-4760相同;F-MLN-4760和F-Aza-MLN-4760对hACE2的IC50值分别比MLN-4760高3倍和7倍。两种示踪剂在HEK-ACE2细胞和移植瘤中均显示特异性摄取,[18F]F-MLN-4760的产率和ACE2结合亲和力优于[18F]F-Aza-MLN-4760,作者认为[18F]F-MLN-4760是进一步开发用于ACE2 PET显像的候选者。
要点
- [18F]F-MLN-4760和[18F]F-Aza-MLN-4760的放射化学纯度均>99%,放射化学产率分别为5.3%和1.2%。
- 3小时孵育后HEK-ACE2细胞摄取:[18F]F-MLN-4760为67±9%,[18F]F-Aza-MLN-4760为37±8%,HEK-ACE细胞摄取<0.3%。
- 移植瘤小鼠1小时p.i.摄取:HEK-ACE2瘤为13±2% IA/g([18F]F-MLN-4760)和15±2% IA/g([18F]F-Aza-MLN-4760),HEK-ACE瘤<0.3% IA/g。
核心结论
- 两种示踪剂在体外和体内均显示对ACE2的特异性和选择性结合。
- [18F]F-MLN-4760产率更高且ACE2结合亲和力优于[18F]F-Aza-MLN-4760。
- 作者认为[18F]F-MLN-4760是进一步开发用于ACE2 PET显像的候选者。
研究设计与样本
- 本研究为示踪剂研制与临床前评价研究,涉及计算机分子建模、共结晶、置换实验、放射化学合成、体外细胞与组织切片结合实验以及小鼠生物分布与PET/CT显像。
- 采用表达hACE2的HEK-ACE2细胞和对照HEK-ACE细胞,以及HEK-ACE2和HEK-ACE移植瘤裸鼠进行评价。
主要发现
- 晶体学数据显示F-MLN-4760与hACE2的结合模式与既往发现的MLN-4760相同。
- 计算机建模表明F-MLN-4760和F-Aza-MLN-4760与hACE2和mACE2的结合与MLN-4760类似。
- F-MLN-4760和F-Aza-MLN-4760对hACE2的IC50值分别比MLN-4760高3倍和7倍。
- [18F]F-MLN-4760和[18F]F-Aza-MLN-4760分别获得1.4±0.3 GBq和0.5±0.1 GBq活度,放射化学纯度>99%,放射化学产率分别为5.3%和1.2%。
- PET/CT显像证实移植瘤特异性摄取,同时可见胆囊和肠道非特异性蓄积。
关键数值与推荐
- 3小时孵育后HEK-ACE2细胞摄取:[18F]F-MLN-4760为67±9%,[18F]F-Aza-MLN-4760为37±8%,HEK-ACE细胞摄取<0.3%。
- HEK-ACE2移植瘤1小时p.i.摄取:[18F]F-MLN-4760为13±2% IA/g,[18F]F-Aza-MLN-4760为15±2% IA/g;HEK-ACE移植瘤摄取<0.3% IA/g。
- F-MLN-4760和F-Aza-MLN-4760对hACE2的IC50值分别比MLN-4760高3倍和7倍。
临床怎么用
- 作者认为[18F]F-MLN-4760是进一步开发用于ACE2 PET显像的候选者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The angiotensin converting enzyme 2 (ACE2) plays a regulatory role in the cardiovascular system and serves SARS-CoV-2 as an entry receptor. The aim of this study was to synthesize and evaluate radiofluorinated derivatives of the ACE2 inhibitor MLN-4760. [18F]F-MLN-4760 and [18F]F-Aza-MLN-4760 were demonstrated to be suitable for non-invasive imaging of ACE2, potentially enabling a better understanding of its expression dynamics. METHODS: Computational molecular modeling, based on the structures of human ACE2 (hACE2) and mouse ACE2 (mACE2), revealed that the ACE2-binding modes of F-MLN-4760 and F-Aza-MLN-4760 were similar to that of MLN-4760. Co-crystallization of the hACE2/F-MLN-4760 protein complex was performed for confirmation. Displacement experiments using [3H]MLN-4760 enabled the determination of the binding affinities of the synthesized F-MLN-4760 and F-Aza-MLN-4760 to hACE2 expressed in HEK-ACE2 cells. Aryl trimethylstannane-based and pyridine-based radiofluorination precursors were synthesized and used for the preparation of the respective radiotracers. [18F]F-MLN-4760 and [18F]F-Aza-MLN-4760 were evaluated with regard to the uptake in HEK-ACE2 and HEK-ACE cells and in vitro binding to tissue sections of HEK-ACE2 xenografts and normal organs of mice. Biodistribution and PET/CT imaging studies of [18F]F-MLN-4760 and [18F]F-Aza-MLN-4760 were performed using HEK-ACE2 and HEK-ACE xenografted nude mice. RESULTS: Crystallography data revealed an equal hACE2-binding mode for F-MLN-4760 as previously found for MLN-4760. Moreover, computer-based modeling indicated that similar binding to hACE2 and mACE2 holds true for both, F-MLN-4760 and F-Aza-MLN-4760, as is the case for MLN-4760. The IC50 values were three-fold and seven-fold higher for F-MLN-4760 and F-Aza-MLN-4760, respectively, than for MLN-4760. [18F]F-MLN-4760 and [18F]F-Aza-MLN-4760 were obtained in 1.4 ± 0.3 GBq and 0.5 ± 0.1 GBq activity with > 99% radiochemical purity in a 5.3% and 1.2% radiochemical yield, respectively. Uptake in HEK-ACE2 cells was higher for [18F]F-MLN-4760 (67 ± 9%) than for [18F]F-Aza-MLN-4760 (37 ± 8%) after 3-h incubation while negligible uptake was seen in HEK-ACE cells (< 0.3%). [18F]F-MLN-4760 and [18F]F-Aza-MLN-4760 accumulated specifically in HEK-ACE2 xenografts of mice (13 ± 2% IA/g and 15 ± 2% IA/g at 1 h p.i.) with almost no uptake observed in HEK-ACE xenografts (< 0.3% IA/g). This was confirmed by PET/CT imaging, which also visualized unspecific accumulation in the gall bladder and intestinal tract. CONCLUSION: Both radiotracers showed specific and selective binding to ACE2 in vitro and in vivo. [18F]F-MLN-4760 was, however, obtained in higher yields and the ACE2-binding affinity was superior over that of [18F]F-Aza-MLN-4760. [18F]F-MLN-4760 would, thus, be the candidate of choice for further development in view of its use for PET imaging of ACE2.
引用
- Wang J, Beyer D, Vaccarin C, et al. Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2. Eur J Nucl Med Mol Imaging. 2024. PMID: 39066808. doi:10.1007/s00259-024-06831-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。